Pronota Company
Pronota develops diagnostic devices for the early detection of conditions such as heart failure, pre-eclampsia and sepsis.
%20.jpg)
%20.jpg)
Total Funding:
$41.2M
Headquarters:
Ghent, Oost-Vlaanderen, Belgium
Funding Status:
Late Stage Venture
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Technology:
Cardiovascular Disorders Diagnostics
Investors Number:
10
Founded Date:
18.10.2004
Industry:
Deep Diagnostics